FDA’s top gene therapy regulator is leaving his role
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The reporting (11)
- UNCY Stock Clocks Worst Day In A Year — Analysts Keep Buy Ratings Despite ‘5-12 Month Delay’ In Drug Approval TradingView · 56d ago
- Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection PharmTech.com · 56d ago
- Unicycive Therapeutics Receives Complete Response Letter GlobeNewswire · 56d ago
- Unicycive shares plunge after FDA issues Complete Response Letter for kidney disease drug (UNCY) Yahoo Finance · 56d ago
- US FDA declines to approve Unicycive's kidney disease drug Reuters · 56d ago
- Top FDA gene and cell therapy regulator to step down Yahoo · 56d ago
- FDA’s cell and gene therapy head steps down after 1 year BioSpace · 56d ago
- FDA’s acting director of cell and gene therapies to leave position Endpoints News · 56d ago
- Top FDA gene and cell therapy regulator to step down BioPharma Dive · 56d ago
- FDA gene therapy regulator Vijay Kumar steps down from leadership role Fierce Biotech · 56d ago
- FDA’s top gene therapy regulator is leaving his role statnews.com · 56d ago broke it first
Related trends
Lego posts record first-half revenue, CEO touts strong sales at high-end and value pricing
Lego's record first‑half revenue, driven by World Cup and premium sets, spotlights a booming toy market.
Druckenmiller, Bessent’s Early Mentor, Calls Bond Buys a Mistake
Stanley Druckenmller brands the U.S. Treasury’s latest bond buyback a credibility‑killing mistake, sparking fresh market debate.
Starbucks’ Pumpkin Spice Latte Is Back, Along With 6 All-New Drinks—and We Tried Them First
Starbucks rolls out its 2026 Pumpkin Spice Latte comeback alongside six brand‑new fall drinks, sparking immediate consumer buzz.
Shooting involving at least one officer after disturbance at Lodi McDonald's, police say
A police shooting following an armed disturbance inside a Lodi McDonald's has drawn heavy local media attention.
FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly
The FDA has granted clearance to a new Alzheimer’s disease blood test developed by Roche and Eli Lilly.
UPS is investing $2 billion in international, healthcare and supply chain businesses
UPS has committed more than $2 billion to accelerate global logistics, targeting international, healthcare, and supply chain sectors.